Quantcast
Channel: Endpoints News
Viewing all articles
Browse latest Browse all 6022

Dualitas gets $65M in Series A to develop bispecifics for immunology

$
0
0
A Bay Area startup is unveiling its first major fundraise as it aims to develop bispecific antibodies for immune and inflammatory diseases. Dualitas Therapeutics (pronounced like doo-AH-luh-toss, not like the singer Dua Lipa) said Tuesday ...

Viewing all articles
Browse latest Browse all 6022

Trending Articles